The LRG Impacts GIST Research
Thriving Together also means impacting GIST research for our patient community. The LRG contributes and collaborates in the research arena in many ways.
Thriving Together also means impacting GIST research for our patient community. The LRG contributes and collaborates in the research arena in many ways.
With your help Fueling GIST Research has soared to new heights! Here's the 'stellar' recap & the results of how our community has fueled GIST research for our Spring campaign.
The Life Raft Group is thankful to those who so generously supported us in 2022 and we hope you continue to support our new initiatives in 2023. #thrivingtogether
LRG Executive Director Sara Rothschild took part in a CME course produced by Medscape titled 'Improving Outcomes & Quality of Life in Advanced GIST: Discussing the Patient Journey and the Latest Data.'
GIST Mentor John Abrams joins the Board of the LRG.
CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors.
Our Good News Holiday Campaign is the culmination of our year of "Time to Tell the Stories 2022." Your donations help us create events to educate and empower our LRG community. Exec Director Sara Rothschild shares her appeal.
The LRG published "Barriers to mutational testing in patients with gastrointestinal stromal tumors (GIST) – a survey of Life Raft Group members" in BMC Gastroenterology, November 2022.
Executive Director & Founder Norman J. Scherzer announced his retirement today after 20+ years of leading the Life Raft Group; former VP of Program Services Sara Rothschild has been appointed to Executive Director position supported by Deputy Executive Director Laura Occhiuzzi, and our experienced LRG staff.
The Connective Tissue Oncology Society (CTOS) meeting was held Nov 18-21st and was chaired by three women in the field. This year’s meeting special because it was held virtually due to COVID-19. One of the new aims of the CTOS organization is to incorporate the patient perspective in more of its sessions.